When was Proscia founded?

Proscia was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is Proscia located?

Proscia is headquartered in Philadelphia, United States. It is registered at Philadelphia · City in Pennsylvania, United States.

How many employees does Proscia have?

As of Mar 31, 2026, the latest employee count at Proscia is 129.

Is Proscia a funded company?

Proscia is a funded company, having raised a total of $129M across 8 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 05, 2016.

When was the latest funding round of Proscia?

Proscia's latest funding was a $***** Series C round on Mar 04, 2025, with participation from 9 investors.

Where does Proscia rank among its competitors?

Proscia ranks 9th amongst 304 active competitors, of which 84 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Proscia, which secured $50M in Mar, 2025.

Who are the top competitors of Proscia?

Proscia's top competitors include PathAI, Ibex and PAIGE. Among them, Proscia secured the most recent funding round in March, 2025.

Proscia - 2026 Company Profile, Team, Funding & Competitors

Proscia is a series C company based in Philadelphia (United States), founded in 2014 by Coleman Stavish, Nathan Buchbinder and David West. It operates as a Provider of an AI and cloud-based digital pathology solution for cancer diagnosis. Proscia has raised $129M in funding from investors like Triangle Peak Partners, Insight Partners and Scale Venture Partners. The company has 304 active competitors, including 84 funded and 16 that have exited. Its top competitors include companies like PathAI, Ibex and PAIGE.

Company Details

Proscia’s is a cloud-based software platform that clinic management, analysis, access, and collaboration for slide images in digital pathology. The features of the Proscia platform that allow users to improve whole slide image workflows include secure storage, annotation, and collaboration on digital biopsies. The company has developed a digital pathology platform called Concentriq that uses AI technology for computational pathology applications. The company has developed a tool that assists helathacre providers to diagnose cancer cells using image analysis technology.

Website: proscia.com
Social
Phone Number: +1 **********
Registered Address: Philadelphia · City in Pennsylvania, United States

Key Metrics

Founded Year

2014

Location

Philadelphia, United States

Stage

Series C

Total Funding

$129M in 8 rounds

Latest Funding Round

Series C, Mar 04, 2025, $*****

Investors

Triangle Peak Partners & 23 more

Ranked

9^th among 304 active competitors

Employee Count

129 as on Mar 31, 2026

Similar Companies

PathAI & 264 more

View Proscia's full profile

Proscia is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Proscia Inc. CIN: 47-1450500 , United States, Active	Jun 30, 2014	-	85 (As on Dec 31, 2022)	-

Proscia has raised a total funding of $129M over 8 rounds. Its first funding round was on Jul 05, 2016. Its latest funding round was a Series C round on Mar 04, 2025 for $*****. 9 investors participated in its latest round. Proscia has 24 institutional investors.

Here is the list of recent funding rounds of Proscia:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 04, 2025	1147383	Series C	2132293	1947371	8924135	1257663
Dec 29, 2023	8649101	Series C	6782724	1022210	3864525	AIC & 2 more
Jun 03, 2022	3696841	Series C	9087700	1496680	2902052	Highline Capital & 7 more

Access funding benchmarks and valuations. Sign up today!

View details of Proscia's funding rounds and investors

The founders of Proscia are Coleman Stavish, Nathan Buchbinder and David West.

Here are the details of Proscia's key team members:

Coleman Stavish: Co-Founder & CTO of Proscia and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 1 email address
Nathan Buchbinder: Co-Founder & Chief Strategy Officer of Proscia.
David West: Co-Founder & CEO of Proscia.
Contact Info: 1 email address

Proscia's Board of Directors

Proscia's board has 12 active members. Alexander Niehenke, David West, Coleman Stavish, Jacob Doft, Tom Loftus, Robert Epstein, Stavish Coleman, Charles M. Hazard, David West, Jr., Neil L. Cohen, David West, Sr. and Alex Niehenke are independent board members.

Here is the list of Proscia's board of directors:

Name	Type	Representing	Status	Duration
Alexander Niehenke	Independent board member	-	Current	5y 3m
u{pbzlw	Independent board member	-	Current	8y 7m
mwesjuq	Independent board member	-	Current	7y 6m
ztsyorn	Independent board member	-	Current	5y 8m
{imgwuj	Independent board member	-	Current	8y 5m
txfwdhf	Independent board member	-	Current	7y 8m
gylwcks	Independent board member	-	Current	2y 1m
buhruqo	Independent board member	-	Current	6y 4m
nrgroao	Independent board member	-	Current	2y 5m
iazyzrj	Independent board member	-	Current	5y 6m
hjbekcm	Independent board member	-	Current	2y 2m
kapxtnn	Independent board member	-	Current	6y 2m

View details of Proscia's Founder profiles and Board Members

Proscia's employee count trend

Proscia has 129 employees as of Mar 26. Here is Proscia's employee count trend over the years:

Uncover Proscia's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Proscia include PathAI, Ibex and PAIGE. Here is the list of Top 10 competitors of Proscia, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PathAI 2016, Boston (United States), Series C	Provider of digital pathology image management system for clinical labs	$255M	General Catalyst, Polaris Partners & 21 others	70/100
2nd	Ibex 2016, Tel Aviv (Israel), Series C	Provider of AI-powered diagnostic solutions for pathology	$114M	83NORTH, Kreos Capital & 6 others	69/100
3rd	PAIGE 2018, New York City (United States), Acquired	Developer of AI applications and foundation models for cancer diagnostics	$241M	Goldman Sachs, Casdin Capital & 9 others	66/100
4th	Pictor Labs 2019, Los Angeles (United States), Series B	AI-based solutions for pathological image analysis	$48.8M	Insight Partners, LabCorp & 4 others	64/100
5th	Aignostics 2018, Berlin (Germany), Series B	Provider of AI-driven solutions for drug development and precision medicine	$53.9M	Wellington Partners Venture Capital, Boehringer Ingelheim Venture Fund ... & 9 others	64/100
6th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	MassMutual, Accomplice & 12 others	62/100
7th	EnSpectra Health 2014, Mountain View (United States), Series A	Developer of medical devices for tissue imagining and cancer detection	$15.5M	Foothill Ventures, Heuristic Capital Partners ... & 5 others	62/100
8th	Nucle AI 2017, Chicago (United States), Series B	AI-assisted platform for image analysis	$60M	Vertex Ventures Israel, Sanofi Ventures & 9 others	62/100
9th	Proscia 2014, Philadelphia (United States), Series C	Provider of an AI and cloud-based digital pathology solution for cancer diagnosis	$129M	Venture for America, Scale Venture Partners ... & 22 others	59/100
10th	Techcyte 2014, Orem (United States), Series B	Artificial intelligence (AI) based image analysis platform for pathologists	$35.4M	ARUP Laboratories, Zoetis & 1 others	58/100